GH Research
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GH Research and other ETFs, options, and stocks.About GHRS
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders.
CEOVelichka Valcheva
CEOVelichka Valcheva
Employees50
Employees50
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2021
Founded2021
Employees50
Employees50
GHRS Key Statistics
Market cap835.52M
Market cap835.52M
Price-Earnings ratio-18.29
Price-Earnings ratio-18.29
Dividend yield—
Dividend yield—
Average volume308.69K
Average volume308.69K
High today$13.86
High today$13.86
Low today$13.39
Low today$13.39
Open price$13.43
Open price$13.43
Volume533.41K
Volume533.41K
52 Week high$20.50
52 Week high$20.50
52 Week low$6.72
52 Week low$6.72
Stock Snapshot
With a market cap of 835.52M, GH Research(GHRS) trades at $13.47. The stock has a price-to-earnings ratio of -18.29.
As of 2025-11-05, GH Research(GHRS) stock has fluctuated between $13.39 and $13.86. The current price stands at $13.47, placing the stock +0.6% above today's low and -2.8% off the high.
The GH Research(GHRS)'s current trading volume is 533.41K, compared to an average daily volume of 308.69K.
In the last year, GH Research(GHRS) shares hit a 52-week high of $20.50 and a 52-week low of $6.72.
In the last year, GH Research(GHRS) shares hit a 52-week high of $20.50 and a 52-week low of $6.72.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GHRS. This list is generated using Robinhood data, and it’s not a recommendation.